Wu Sun

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Monoclonal Antibody

Radiation Induced

Inflammatory Response

Top Venues

Future oncology (London, England)

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Minghui Liu, Huan Zhao, Suming Peng, Yunfei Wu, Yanyan Liu, Wu Sun, Ke Zen, Xinlei Sun
Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (5) (2024)
Minghui Liu, Huan Zhao, Suming Peng, Yunfei Wu, Yanyan Liu, Wu Sun, Ke Zen, Xinlei Sun
Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (5) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) 20 (17) (2024)
Limei Min, Xiaolu Wang, Anni Chen, Yingling Zhou, Yu-Chen Ge, Juanjuan Dai, Xiaofeng Chang, Wu Sun, Qin Liu, Xia Zhou, Manman Tian, Wentao Kong, Junmeng Zhu, Jie Shen, Baorui Liu, Ru-Tian Li
Design of a single-center, phase II trial to explore the efficacy and safety of 'R-ISV-RO' treatment in advanced tumors. Future oncology (London, England) (2024)
Yajing Qu, Haiyang Zhang, Wu Sun, Yueting Han, Shuang Li, Yanjun Qu, Guoguang Ying, Yi Ba
MicroRNA-155 promotes gastric cancer growth and invasion by negatively regulating transforming growth factor-β receptor 2. Cancer science 109 (3) (2018)